N-hydroxy-N'-phenyloctanediamide
GPTKB entity
Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
histone deacetylase inhibitor |
gptkbp:alternativeName |
gptkb:SAHA
gptkb:suberoylanilide_hydroxamic_acid |
gptkbp:ATCCode |
L01XX50
|
gptkbp:CASNumber |
149647-78-9
|
gptkbp:hasInChIKey |
LFYFEWAGGLJEEJ-UHFFFAOYSA-N
|
gptkbp:hasMolecularFormula |
C14H20N2O2
|
gptkbp:hasSMILES |
C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
|
https://www.w3.org/2000/01/rdf-schema#label |
N-hydroxy-N'-phenyloctanediamide
|
gptkbp:is_approved_for_treatment_of |
leukemia
|
gptkbp:IUPACName |
gptkb:N-hydroxy-N'-phenyloctanediamide
|
gptkbp:mechanismOfAction |
inhibits histone deacetylases
|
gptkbp:meltingPoint |
151-153°C
|
gptkbp:partOf |
vorinostat (pharmaceutical preparation)
|
gptkbp:PubChem_CID |
5311
|
gptkbp:routeOfAdministration |
oral
intravenous |
gptkbp:usedFor |
anticancer agent
epigenetic drug |
gptkbp:was_approved_by |
gptkb:FDA
|
gptkbp:bfsParent |
gptkb:vorinostat
|
gptkbp:bfsLayer |
6
|